Capsida Biotherapeutics
Pre-clinicalCapsida Biotherapeutics is an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies for patients with debilitating and life-threatening disorders.
Founded
2019
Focus
RNA & Gene TherapyViral Technology
About
Capsida Biotherapeutics is an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies for patients with debilitating and life-threatening disorders.
Funding History
4Total raised: $630M
Series B$175MEli LillyJan 15, 2023
Series B$175MEli LillyJan 15, 2023
Series A$140MVersant VenturesMay 15, 2021
Series A$140MVersant VenturesMay 15, 2021
Company Info
TypePrivate
Founded2019
LocationThousand Oaks, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile